A citation-based method for searching scientific literature

Narjust Duma, Rafael Santana-Davila, Julian R Molina. Mayo Clin Proc 2019
Times Cited: 626







List of co-cited articles
241 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The biology and management of non-small cell lung cancer.
Roy S Herbst, Daniel Morgensztern, Chris Boshoff. Nature 2018
26

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
18

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
18

Lung cancer: current therapies and new targeted treatments.
Fred R Hirsch, Giorgio V Scagliotti, James L Mulshine, Regina Kwon, Walter J Curran, Yi-Long Wu, Luis Paz-Ares. Lancet 2017
9

Cancer Statistics, 2021.
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2021
9

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
8

Lung Cancer 2020: Epidemiology, Etiology, and Prevention.
Brett C Bade, Charles S Dela Cruz. Clin Chest Med 2020
487
8


Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
Leena Gandhi, Delvys Rodríguez-Abreu, Shirish Gadgeel, Emilio Esteban, Enriqueta Felip, Flávia De Angelis, Manuel Domine, Philip Clingan, Maximilian J Hochmair, Steven F Powell,[...]. N Engl J Med 2018
6

Non-small cell lung cancer: current treatment and future advances.
Cecilia Zappa, Shaker A Mousa. Transl Lung Cancer Res 2016
795
6


TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells.
Taiwen Li, Jingyu Fan, Binbin Wang, Nicole Traugh, Qianming Chen, Jun S Liu, Bo Li, X Shirley Liu. Cancer Res 2017
6

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.
Zefang Tang, Chenwei Li, Boxi Kang, Ge Gao, Cheng Li, Zemin Zhang. Nucleic Acids Res 2017
6

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial.
Tony S K Mok, Yi-Long Wu, Iveta Kudaba, Dariusz M Kowalski, Byoung Chul Cho, Hande Z Turna, Gilberto Castro, Vichien Srimuninnimit, Konstantin K Laktionov, Igor Bondarenko,[...]. Lancet 2019
6

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer.
Peter Goldstraw, Kari Chansky, John Crowley, Ramon Rami-Porta, Hisao Asamura, Wilfried E E Eberhardt, Andrew G Nicholson, Patti Groome, Alan Mitchell, Vanessa Bolejack. J Thorac Oncol 2016
5

Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
P E Postmus, K M Kerr, M Oudkerk, S Senan, D A Waller, J Vansteenkiste, C Escriu, S Peters. Ann Oncol 2017
817
5

Molecular testing and targeted therapy for non-small cell lung cancer: Current status and perspectives.
Evgeny N Imyanitov, Aglaya G Iyevleva, Evgeny V Levchenko. Crit Rev Oncol Hematol 2021
106
5

Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.
Jean-Charles Soria, Yuichiro Ohe, Johan Vansteenkiste, Thanyanan Reungwetwattana, Busyamas Chewaskulyong, Ki Hyeong Lee, Arunee Dechaphunkul, Fumio Imamura, Naoyuki Nogami, Takayasu Kurata,[...]. N Engl J Med 2018
4

Global Epidemiology of Lung Cancer.
Julie A Barta, Charles A Powell, Juan P Wisnivesky. Ann Glob Health 2019
499
4

The biogenesis, biology and characterization of circular RNAs.
Lasse S Kristensen, Maria S Andersen, Lotte V W Stagsted, Karoline K Ebbesen, Thomas B Hansen, Jørgen Kjems. Nat Rev Genet 2019
4

NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.
David S Ettinger, Douglas E Wood, Dara L Aisner, Wallace Akerley, Jessica R Bauman, Ankit Bharat, Debora S Bruno, Joe Y Chang, Lucian R Chirieac, Thomas A D'Amico,[...]. J Natl Compr Canc Netw 2021
309
4

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer.
Martin Reck, Delvys Rodríguez-Abreu, Andrew G Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinead Cuffe,[...]. N Engl J Med 2016
4

Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLC.
D Ross Camidge, Robert C Doebele, Keith M Kerr. Nat Rev Clin Oncol 2019
237
4

Non-small-cell lung cancers: a heterogeneous set of diseases.
Zhao Chen, Christine M Fillmore, Peter S Hammerman, Carla F Kim, Kwok-Kin Wong. Nat Rev Cancer 2014
980
4

PD-L1 expression in advanced NSCLC: Insights into risk stratification and treatment selection from a systematic literature review.
Robert Brody, Yiduo Zhang, Marc Ballas, Mohd Kashif Siddiqui, Palvi Gupta, Craig Barker, Anita Midha, Jill Walker. Lung Cancer 2017
141
4

Cancer statistics, 2019.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2019
4

Robust enumeration of cell subsets from tissue expression profiles.
Aaron M Newman, Chih Long Liu, Michael R Green, Andrew J Gentles, Weiguo Feng, Yue Xu, Chuong D Hoang, Maximilian Diehn, Ash A Alizadeh. Nat Methods 2015
4

Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer.
Luis Paz-Ares, Alexander Luft, David Vicente, Ali Tafreshi, Mahmut Gümüş, Julien Mazières, Barbara Hermes, Filiz Çay Şenler, Tibor Csőszi, Andrea Fülöp,[...]. N Engl J Med 2018
3


Immunotherapy in Non-Small Cell Lung Cancer: Facts and Hopes.
Deborah B Doroshow, Miguel F Sanmamed, Katherine Hastings, Katerina Politi, David L Rimm, Lieping Chen, Ignacio Melero, Kurt A Schalper, Roy S Herbst. Clin Cancer Res 2019
289
3

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors.
Lecia V Sequist, Belinda A Waltman, Dora Dias-Santagata, Subba Digumarthy, Alexa B Turke, Panos Fidias, Kristin Bergethon, Alice T Shaw, Scott Gettinger, Arjola K Cosper,[...]. Sci Transl Med 2011
3


International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma.
William D Travis, Elisabeth Brambilla, Masayuki Noguchi, Andrew G Nicholson, Kim R Geisinger, Yasushi Yatabe, David G Beer, Charles A Powell, Gregory J Riely, Paul E Van Schil,[...]. J Thorac Oncol 2011
3

Circular RNAs in cancer: opportunities and challenges in the field.
L S Kristensen, T B Hansen, M T Venø, J Kjems. Oncogene 2018
854
3

Over-expression of CircRNA_100876 in non-small cell lung cancer and its prognostic value.
Jun-Tao Yao, Shu-Hong Zhao, Qiu-Ping Liu, Mo-Qi Lv, Dang-Xia Zhou, Zi-Jun Liao, Ke-Jun Nan. Pathol Res Pract 2017
191
3


Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
Scott J Antonia, Augusto Villegas, Davey Daniel, David Vicente, Shuji Murakami, Rina Hui, Takashi Yokoi, Alberto Chiappori, Ki H Lee, Maike de Wit,[...]. N Engl J Med 2017
3

Reduced lung-cancer mortality with low-dose computed tomographic screening.
Denise R Aberle, Amanda M Adams, Christine D Berg, William C Black, Jonathan D Clapp, Richard M Fagerstrom, Ilana F Gareen, Constantine Gatsonis, Pamela M Marcus, JoRean D Sicks. N Engl J Med 2011
3

The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.
William D Travis, Elisabeth Brambilla, Andrew G Nicholson, Yasushi Yatabe, John H M Austin, Mary Beth Beasley, Lucian R Chirieac, Sanja Dacic, Edwina Duhig, Douglas B Flieder,[...]. J Thorac Oncol 2015
3

ceRNA in cancer: possible functions and clinical implications.
Xiaolong Qi, Da-Hong Zhang, Nan Wu, Jun-Hua Xiao, Xiang Wang, Wang Ma. J Med Genet 2015
738
3

Natural RNA circles function as efficient microRNA sponges.
Thomas B Hansen, Trine I Jensen, Bettina H Clausen, Jesper B Bramsen, Bente Finsen, Christian K Damgaard, Jørgen Kjems. Nature 2013
3

Osimertinib and other third-generation EGFR TKI in EGFR-mutant NSCLC patients.
J Remon, C E Steuer, S S Ramalingam, E Felip. Ann Oncol 2018
72
4

Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer.
Longqiang Wang, Xin Tong, Zhengyu Zhou, Shengjie Wang, Zhe Lei, Tianze Zhang, Zeyi Liu, Yuanyuan Zeng, Chang Li, Jun Zhao,[...]. Mol Cancer 2018
210
3


CircRNA_101237 promotes NSCLC progression via the miRNA-490-3p/MAPK1 axis.
Zhi-Ye Zhang, Xiao-Hui Gao, Ming-Ying Ma, Chun-Ling Zhao, Ya-Li Zhang, Shuang-Shuang Guo. Sci Rep 2020
58
5

miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives.
Mateusz Florczuk, Adam Szpechcinski, Joanna Chorostowska-Wynimko. Target Oncol 2017
72
4

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.
J Guillermo Paez, Pasi A Jänne, Jeffrey C Lee, Sean Tracy, Heidi Greulich, Stacey Gabriel, Paula Herman, Frederic J Kaye, Neal Lindeman, Titus J Boggon,[...]. Science 2004
3


EGFR mutations and lung cancer.
Gilda da Cunha Santos, Frances A Shepherd, Ming Sound Tsao. Annu Rev Pathol 2011
409
3

CircRNA: a rising star in gastric cancer.
Rong Li, Jiajia Jiang, Hui Shi, Hui Qian, Xu Zhang, Wenrong Xu. Cell Mol Life Sci 2020
170
3


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.